Ahmet Dogan mainly focuses on Lymphoma, Pathology, Cancer research, MALT lymphoma and Internal medicine. Ahmet Dogan is involved in the study of Lymphoma that focuses on Follicular lymphoma in particular. His Pathology study combines topics in areas such as Immunophenotyping and Angioimmunoblastic T-cell lymphoma.
The study incorporates disciplines such as International Prognostic Index, Diffuse large B-cell lymphoma, Cell growth, Large-cell lymphoma and Syk in addition to Cancer research. His biological study spans a wide range of topics, including BCL10, Molecular biology and Mantle zone. His Internal medicine research focuses on subjects like Gastroenterology, which are linked to Refractory, Disease, Surgery, Allogeneic transplantation and Survival rate.
His main research concerns Pathology, Lymphoma, Internal medicine, Cancer research and Oncology. His research brings together the fields of Immunoglobulin light chain and Pathology. His Lymphoma study contributes to a more complete understanding of Immunology.
His Cancer research research includes themes of Gene expression profiling and Chromosomal translocation. His Oncology study combines topics from a wide range of disciplines, such as Single-nucleotide polymorphism and Bioinformatics. He usually deals with Amyloidosis and limits it to topics linked to Amyloid and Transthyretin.
Ahmet Dogan mainly investigates Internal medicine, Cancer research, Oncology, Lymphoma and Multiple myeloma. His research in Internal medicine tackles topics such as Gastroenterology which are related to areas like Rituximab. Ahmet Dogan interconnects Mutation, Cancer cell, Somatic cell and Monoclonal in the investigation of issues within Cancer research.
His Oncology research focuses on Lenalidomide and how it connects with Phases of clinical research. His Lymphoma study is related to the wider topic of Pathology. His study in the field of Mucosa-associated lymphoid tissue also crosses realms of Extramural.
Ahmet Dogan spends much of his time researching Internal medicine, Lymphoma, Cancer research, Oncology and Multiple myeloma. In Internal medicine, Ahmet Dogan works on issues like Gastroenterology, which are connected to Autologous stem-cell transplantation. His Lymphoma research is multidisciplinary, incorporating elements of Retrospective cohort study and Cohort.
His studies deal with areas such as Mutation, Histiocytoses, MAPK/ERK pathway and Somatic cell as well as Cancer research. His research in Oncology intersects with topics in Patient population, Venetoclax, Obinutuzumab, Chronic lymphocytic leukemia and Relapsed refractory. His work deals with themes such as Immunoglobulin light chain, Computational biology and Gene, which intersect with Multiple myeloma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Immunoproliferative small-intestinal disease. An immunohistochemical study.
Peter G. Isaacson;Ahmet Dogan;Stephen K. Price;Jo Spencer.
The American Journal of Surgical Pathology (1989)
The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website
S Bamford;E Dawson;S Forbes;J Clements.
British Journal of Cancer (2004)
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
Jens G. Lohr;Petar Stojanov;Petar Stojanov;Michael S. Lawrence;Daniel Auclair.
Proceedings of the National Academy of Sciences of the United States of America (2012)
Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.
Julie A. Vrana;Jeffrey D. Gamez;Benjamin J. Madden;Jason D. Theis.
Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy
Hongxiang Liu;Agnes Ruskon-Fourmestraux;Anne Lavergne-Slove;Hongtao Ye.
The Lancet (2001)
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
Hongxiang Liu;Hongtao Ye;Agnes RuskoneFourmestraux;Daphne De Jong.
CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
Ahmet Dogan;Eniko Bagdi;Philippa Munson;Peter G. Isaacson.
The American Journal of Surgical Pathology (2000)
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R. Parrilla Castellar;Elaine S. Jaffe;Jonathan W. Said;Steven H. Swerdlow.
Angioimmunoblastic T‐cell lymphoma
Ahmet Dogan;Ayoma D. Attygalle;Chara Kyriakou.
British Journal of Haematology (2003)
Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma
Hongtao Ye;Hongxiang Liu;Ayoma Attygalle;Andrew C. Wotherspoon.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: